Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-02-001848
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
12
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d50097form10-k.htm 10-K 747507
3 GRAPHIC g50097figure1.jpg GRAPHIC 52669
4 GRAPHIC g50097figure3.jpg GRAPHIC 53489
5 JOINT VENTURE AGREEMENT d50097_ex10-24.htm EX-10.24 199585
6 LAND PURCHASE AND SALE AGREEMENT d50097_ex10-25.htm EX-10.25 77922
7 CONTRIBUTION AGREEMENT d50097_ex10-26.htm EX-10.26 16316
8 EMPLOYMENT AGREEMENT d50097_ex10-27.htm EX-10.27 83849
9 EMPLOYMENT AGREEMENT d50097_ex10-28.htm EX-10.28 95401
10 SUBLEASE AGREEMENT d50097_ex10-29.htm EX-10.29 56544
11 STOCK OPTION AGREEMENT d50097_ex10-30.htm EX-10.30 23519
12 ASSIGNMENT AGREEMENT d50097_ex10-31.htm EX-10.31 12811
13 CONSENT OF INDEPENDENT AUDITORS d50097_ex23-1.htm EX-23.1 2394
  Complete submission text file 0000891554-02-001848.txt   1424872
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 02597306
SIC: 2834 Pharmaceutical Preparations